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Summary The reactivity of murine monoclonal antibodies (McAbs) directed against the monomorphic
determinants of Class I and Class II antigens of the major histocompatibility complex (MHC), and against
antigens expressed by discrete populations of leucocytes was studied using the indirect immunoperoxidase
technique on serial tissue sections of 16 benign and 17 malignant primary human breast tumours. Class I
antigens (detected by the McAb 2AI) were consistently associated with stromal leucocytes, fibroblasts and
vascular endothelium, but expression on epithelial cells particularly of malignant provenance, was more
variable. Class II antigens (detected by TDR 31.1) were present upon a variety of cell types which also
included sporadic expression on malignant and benign epithelia. The distribution of leucocytes grossly
monitored with 2D1 (reactive with a common leucocyte antigen) was largely interepithelial and periductal in
benign lesions. Leucocytes were generally more numerous in malignant tumours, where they were largely
confined to the stroma. The majority (-75%) of leucocytes were T lymphocytes (reactive with UCHT1),
some of which appeared to react with TDR 31.1 and were therefore activated. Ratios of helper/inducer
(OKT4+) and suppressor/cytotoxic (OKT8+) subsets generally exceeded unity in malignant neoplasms. There
was no correlation between the extent and distribution of T cells and the HLA status of the epithelial cells.
Leucocytes detected by the monoclonal antibody OKM 1 which reacts with monocytes/macrophages,
granulocytes and large granular lymphocytes were numerically few and again mainly confined to the stroma.
In a limited number of tests, leucocytes detected with HNK1, reactive with a differentiation antigen expressed
on some cells which mediate natural and antibody-dependent cellular cytotoxicity in vitro although detectable
interepithelially in benign tumours, were virtually absent from malignant tissue. HNK1 also cross-reacted with
myoepithelial cells in the ducts of benign lesions.
Human malignant neoplasms not infrequently
reveal mononuclear cell infiltrates which have
features in common with immune-associated
inflammatory reactions (Underwood, 1974).
Although there is limited evidence for tumour-
related functional activity in the infiltrating
leucocyte compartment (see Haskill, 1983), the
relationship of the phenomenon at a functional or
histological level to biological behaviour remains
largely obscure.
The majority of solid human neoplasms are
characterised by marked cellular heterogeneity and
any provisional assignment of in situ function will
require the elucidation of the heterogeneity and
microanatomical distribution of potential leucocytic
effector cells relative to the tumour population.
Such an analysis must also extend to the neoplastic
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compartment itself. Human tumour cells are
phenotypically diverse (Woodruff, 1983) and
although several useful markers exist (Lennox &
Sikora, 1982) the antigens which evoke cellular
immune responses have not been serologically
defined.
The initiation of the present study coincided with
reports of heterogeneity of expression of Class I
(Fleming et al., 1981) and anomalous expression of
Class II (DR) antigens (Natali et al., 1981a; Daar
et al., 1982) of the major histocompatibility
complex (MHC) on primary human tumours. Since
these MHC products have a crucial role in cell:cell
interactions involving both the inductive and
effector phases of the immune response it seemed
reasonable to examine, as a preliminary approach,
the HLA status of primary tumours in conjunction
with leucocyte infiltration. For this purpose we
have deployed the indirect immunoperoxidase
technique using monoclonal antibodies (McAbs)
against the major leucocyte populations and their
subsets and McAbs to the monomorphic
determinants of the HLA Class I and Class II
antigens. Breast was the tissue of choice on account
of the availability of benign and malignant tissue
from the same organ and the absence of infection.
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We report here that the T lymphocyte-
predominant leucocyte infiltrates of malignant
tumours are quantitatively greater than those of
benign neoplasms, there is no simple correlation
with the expression of either MHC Class I or
Class II antigens on the tumour cells; that
the lymphocytic reaction, comprising T-helper and
T-suppressor cells, usually in order of their
frequency in peripheral blood, is confined mainly to
the stroma and that the numbers of potential
effector cells of whatever provenance (lymphoid or
myelomonocytic) within the tumour mass are small.
Patients and methods
Patients
The patients were all admitted for excision/frozen
section of a breast lump. Diagnosis was made on
the frozen section and in all but one of the
malignant cases mastectomy with or without
axillary lymph clearance was carried out. Histo-
logical diagnosis was confirmed on paraffin
sections.
Of the patients with benign breast lesions the age
range was 22-65 years. Two patients (050 and 048)
were taking oral contraceptives at the time of
operation; none of the others were taking steroidal
or anti-inflammatory drugs. In the malignant group
the age range was 50-78 years.
One patient (046) had had a previous left
mastectomy for carcinoma of the breast 6 years
before with radiotherapy (left side only) and
stilboestrol therapy. At the time of the right
mastectomy (for a histologically similar tumour) the
patient was taking tamoxifen only.
One patient (049) had a history of radiotherapy
to the genito-urinary tract 15 years previously for
an unknown reason.
One patient (022) with longstanding rheumatoid
arthritis was taking cimetidine and ketoprofen, a
non-steroidal anti-inflammatory agent.
Tissue specimens
Firm tissue from the tumour mass (mastectomy
specimens and excision biopsies) was wrapped in tin
foil, snap frozen in liquid nitrogen and stored at
-70°C or over liquid nitrogen. Serial sections 5-
10pm thick (depending on the properties of the
section) were cut, dried at 37°C for 30min and
stored at -20°C under desiccated conditions prior
to examination within 7 days. Prolonged storage at
-200C appeared to have detrimental effects on
certain antigens, for example, those recognised by
the OKT4 and HNK-1 antibodies.
Immunohistochemical staining
Sections were fixed in acetone at room temperature
for 5min, air-dried and immersed in 20% newborn
calf serum (NBCS, Flow Labs.) in Tris-HCl
buffered saline (TBS; pH7.5, 0.05M Tris; 0.85%
NaCl). Excess buffered NBCS was wiped away
from the sections and they were incubated in the
monoclonal first layer (TBS without McAb on
control sections) for 60min at 37°C in 100%
relative humidity. Excess antibody was drained and
the sections were washed for 3 x 5min in TBS.
They were then incubated in 1/250 dilution of horse
radish peroxidase conjugated rabbit anti-mouse IgG
(Dako) in TBS containing 6.6% normal human
serum. Following 60min incubation (37°C, 100%
relative humidity) and 3 x 5min washes in TBS,
sections were incubated with 60mg%
diaminobenzidine. Immediately before use, the
diaminobenzidine solution was filtered and 60,ul
H202/100ml substrate was added. Following
incubation for 5-10min sections were washed in
TBS. The staining of those incubated with OKT4
or HNK-1 was enhanced by immersion in 1%
phosphate-buffered osmium tetroxide for 2min and
subsequent washing in TBS. This did not affect the
specificity of the reactions, but helped to visualise
those cells the staining of which otherwise tended
to be weak. Consequently, a more accurate
assessment of the distribution of HNK1 + cells and
of T4/T8 ratios could be made. The sections were
then washed in distilled water, counterstained for
5sec, in Gill's no. 2 Haemalum, blued in hot tap
water, dehydrated in a series of graded alcohols
(50, 70, 95, and 100%) and cleared in xylene.
Permanent mounts were made in Styrolyte
(Raymond Lamb). The specificity of the antibodies
was routinely controlled on sections of palatine
tonsils. Staining in tissue sections treated with
diaminobenzidine and hydrogen peroxide alone
was routinely negligible in breast tissue.
Monoclonal antibodies
The following murine McAbs were used in this
study:
2AI IgGI antibody identifying human HLA Class
I (HLA-A, B, C) non-polymorphic determinant
(Beverley, 1980).
TDR31.1 IgGI antibody recognising human HLA
Class II (HLA-DR) monomorphic determinant
(DeKretser et al., 1982). This reagent was supplied
as purified culture supernatant (400jgml') and
used at 1/200 dilution.
MASO20 IgGI antibody against human B cells
(Clone 5/11 HLK) recognising a site close to theHLA & LEUCOCYTE ANTIGENS IN BREAST DISEASE 163
monomorphic determinant of the DR molecule
(Trucco et al., 1979). This antibody was not
identical to TDR 31.1.
2DI IgGI antibody directed against a human
haemopoietic cell antigen (HLeI) of mol.wt. 70K
dalton present on lymphoid and myeloid cells,
weakly expressed on granulocytes, monocytes and
early erythroid precursors. Absent from a wide
variety ofepithelia (Beverley et al., 1980).
UCHTJ IgGl antibody reactive with antigen of
19K dalton mol.wt. expressed on peripheral T cells
and showing identical reactivity with the mono-
clonal antibody OKT3 (Kung et al., 1979).
OKT4 IgG2b antibody reactive with 62K dalton
mol.wt. antigen expressed on human T cells of
helper/inducer subclass (TH2 -T cells) (Kung et al.,
1979; Reinherz et al., 1979a, b).
OKT8 IgG2a antibody reactive with an undefined
antigen of peripheral T cells of cytotoxic/suppressor
subclass (TH2+) (Reinherz et al., 1980).
OKMI IgG2b antibody reactive with mature
monocytes, granulocytes and certain circulating null
cells (Breard et al., 1980) including cells which
mediate NK activity (Zarling & Kung, 1980) and
antibody-dependent cellular cytotoxicity (Kay &
Horowitz, 1980).
HNK-1 IgM antibody (Leu 7) which defines a
differentiation antigen selectively expressed on NK
and antibody-dependent killer (K) cells (Abo &
Balch, 1981).
TDR31.1 was a gift of Drs W. and J. Bodmer,
Imperial Cancer Research Fund, London and 2A1,
2D1 and UCHT1, generous gifts of Dr P.C.L.
Beverley, ICRF Human Tumour Immunology Unit,
University College Hospital, London. OKT4,
OKT8 and OKM1 were supplied by Ortho
Pharmaceutical Corporation, New Jersey, USA;
MAS020 by Sera-Lab, UK and HNK-1 by Becton
Dickinson Monoclonal Center, Inc., USA.
Results
Histopathological and immunocytochemical data
on sections from the 16 benign and 17 malignant
tissues are summarised in Tables I and II.
2A1 (anti HLA, -A, -B, -C)
Antigens recognised by this antibody which stained
both the membrane and cytoplasm were detected
consistently on the leucocytes, as well as endothelial
cells and stromal fibroblasts of tumour tissue, but
c
some epithelial cells of benign and malignant tissue
were negative while others were positive with
various degrees of staining intensity (Figure 1). In
5/16 benign tissue specimens staining was uniform
but in the remaining 11 it was more variable.
However, by contrast with the malignant tumours
none of the benign lesions exhibited completely
negative staining of epithelial cells with this McAb.
Uniform staining of epithelial cells was not
observed in any of the 17 malignant tissue
specimens. In 8, the pattern was heterogeneous (e.g.
Figure 2) while the remainder were uniformly
negative. There was no correlation between 2A1
and TDR31.1, 2D1 or UCHT1 staining.
TDR31.1 (anti HLA-DR)
Reactivity with antibody ranged from weak,
intermittent to strong membrane and cytoplasmic
staining (Figure 3) of both the cells of benign and
malignant tissues.
Lymphoid and non-lymphoid cells appeared to
be stained, the latter comprising a range of
morphological features including benign and
malignant epithelial cells, elongated cells
reminiscent of dendritic cells, endothelial cells in
capillaries and macrophages. The staining of
epithelial cells, benign and malignant - was
sporadic and never uniform.
There was no correlation between epithelial
TDR31.1 and 2D1 (or UCHT1) staining. However,
lymphoid cells stained with TDR31.1 although
numerically fewer were positively correlated with
those stained with 2D1 and UCHT1 (Tables I and
II).
2D1 (anti leucocyte)
Epithelial cells in all specimens were negative for
antigens detected by this antibody. The majority of
positive cells possessed the rounded morphology
characteristic of lymphoid cells but occasional
elongated cells mostly resembling fibroblasts in the
periductular stroma were also stained. Round cell
staining was mainly confined to the inter-epithelial
and periductal areas in benign tissues, while
elongated cells were most frequently found in the
stroma (Figure 4).
Round cell staining was a more frequent and
prominent feature of malignant than benign tissue
and not, by contrast with the latter, principally
found in association with ducts. Positive cells were
characteristically found in the stroma surrounding
tumour foci, with relatively few actually detectable
within the tumour mass (Figure 5). There appeared
to be no correlation between the extent and
distribution of 2DI staining and necrosis.
UCHTI (anti pan T cell)
Staining patterns observed with UCHT1 were164 H.L. WHITWELL et al.
Table I Summary ofimmunohistological data derived from serial sections of 16 benign breast tumours
Epithelial
Cell Inflammatory cell infiltrate staininga
Patient stainingb OKT4/8
no. Age Histology 2A1 TDR31.J TDR31.J 2DJ UCHTJ MAS020 ratio OKMJ
002 37 Adenosis +/- +/- + ++ ++ ++ >1
048 22 Adenosis + +1- ++ ++ ++ + >1 +
031 49 Adenosis + +/- ++ + + + ++ - >1
047 32 Adenosis + +/- ++ ++ + ++ ND
006 32 Adenosis/fibrosis +/- +1- + ++ ++ + >1
013 33 Adenosis/fibrosis +/- +1- ++ + + + ++ + >1 +
014 51 Adenosis/fibrosis +/- +1- ++ ++ + + >1 +
041 45 Adenosis, fibrosis,
duct ectasia +/- -1+ ++ + + + + + >1 +
007 65 Mild fibrosis +/- -1+ + + + - > 1
042 49 Cystic mastopathy +- -+ + + + + + + + < 1
023 44 Sclerosing adenosis +- -1+ ++ + + + - <1 +
036 43 Adenosis/epitheliosis +/- +1- ++ + + + + + >1 +
020 59 Duct ectasia,
epitheliosis, + +- +++ + + + + + + + >1 +
035 43 Fibroadenoma +/- +- + + + + + + + + ND
045 32 Fibroadenoma + +- + + + + + + + <1 +
050 27 Fibroadenoma +/- +1- ++ +++ + + + >1 +
ND=Not Done.
aStaining reactions are scored on a semi-quantitative scale from 4+ (many cells stained) to - (no cells stained) for the
inflammatory cell infiltrate, apart from OKM1 where the relative scale is from + to -.
bStaining reactions with anti-HLA antibodies are denoted by + (homogeneous staining); - (no staining) and +/-
(heterogeneous staining).
similar in microanatomical distribution to those of
2D1 (Figures 6 and 7) such that UCHTI + cells
accounted for - 75% 2D1 + cells, regardless of the
tissue examined. Some positive cells were noticeably
larger than others and possibly corresponded to T
cell blasts. 2D1 and UCHTI staining was broadly
correlated with lymphoid TDR31.1 staining (Tables
I and II). Virtually none of the UCHTI+ cells in
the few malignant tumours also examined with
HNK-1 (see below) appeared to react with the
latter antibody, although certain similarities in the
patterns of staining were observed in some benign
lesions.
OKT4/OKT8 (anti T helper/inducerIT suppressorl
cytotoxic subsets
OKT4/OKT8 ratios exceeded unity in the majority
of benign (11/14) and malignant (12/17) tissues (e.g.
Figures 8 & 9), and there was no evidence of
microanatomic segregation, the pattern of
distribution following that of UCHTI + cells in
both benign and malignant tissues.
MAS020 (anti B cell)
Relatively few cells were stained with this McAb.
Benign tissues were mainly characterised by the
presence of small numbers ofpositive interepithelial
cells. In the periductal areas and in stromal tissue,
occasional staining was observed which appeared to
correspond to fibroblasts. Epithelial cells were
negative but a proportion of endothelial cells in
some sections were positive. A feature in common
with OKM1 was the staining of intraluminal
material.
HNKI (anti NK/K cells)
The numbers of specimens stained with this
antibody were limited. No positive cells were
observed in 3 malignant tissues, two of which - 003
and 009 - had marked leucocyte infiltrates. Tissues
positive for OKM1 (003 and 010) were negative for
HNK1. Two of 5 benign tissues (cases 002 and 014)
gave positive reactions essentially confined to the
ductal and periductal regions as described for
UCHTI, 2D1 and OKM1 but to a quantitatively
lesser extent. Of considerable interest was the
reactivity, characteristic of this antibody, observed
against myoepithelial cells (Figure 10) including
their cytoplasmic processes.
OKMI (anti monocyte/large granular lymphocyte)
Relative to 2D1, cells reactive with this antibody
were generally fewer in all sections examined. In
benign tissues, OKM1+ cells with the morphologyHLA & LEUCOCYTE ANTIGENS IN BREAST DISEASE 165
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of macrophages were most obvious in and around
dilated ducts (Figure 11). In malignant tumours,
staining from virtually none at all to clusters of
cells again resembling macrophages were almost
invariably confined to the stroma (Figure 12). A
further feature of this McAb was staining of
intraluminal cells (? macrophages) and acellular
material in ducts of benign lesions (cf. MAS020)
though not all ducts in a given section were
necessarily positive in this respect.
Discussion
The identification and characterisation of the
various cell types involved at the host:tumour
interface should ideally be carried out in situ under
conditions where the structural integrity of the
tissue is retained. Only in these circumstances can
the inter-relationship between diverse cell
populations be properly observed. The problem
then becomes how to assign function into literally
static milieu of interacting cells. Hitherto, the
identification of immune cells in tissue sections has
been largely limited to morphology but the recent
availability of McAbs against different lymphocyte
subsets offers the potential to interpret histological
data in functional terms. Likewise, McAbs reactive
with tumour cell membrane components may
provide some insight into the extent of tumour
heterogeneity and in the case of products of the
MHC, have important implications for cell-cell
interactions in the inductive and effector phases of
the immune response.
Notwithstanding such advances, studies of this
type are not without interpretative difficulties.
Apart from being limited to a single time point in
the natural history of the disease, the subdivision of
specimens to meet the requirements of diagnostic
histopathology, may introduce unavoidable
sampling errors. Although reproducibility was
within acceptable limits on serial sections from the
same portion of tumour, there was virtually no
opportunity for a direct comparison of the centre
versus periphery.
A further problem is the identification of cells in
circumstances where a determinant recognised by a
given antibody is expressed by several cell types
which cannot be unequivocally distinguished solely
on morphological grounds. Although interpretation
is to some extent assisted by the availability of
other more definitive markers for cells of a given
lineage, the distinction between some cell types
requires the application of double-labelling
techniques, which were beyond the scope of the
present study.
While consistent staining of leucocytes and
stromal cells was obtained with the anti-HLA-A,
-B, -C, McAb (2A1), reactivity with tumour cells
particularly of malignant provenance was less
predictable. Focal staining indicative of
heterogeneity of Class I antigen expression
characterised many sections - malignant and benign
and approximately one-half of the former were
negative for this antibody under conditions where
adjacent stromal tissue was strongly positive. In this
respect our data are similar to those of Fleming et
al. (1981) who using immunofluorescence with the
McAb PA 2.6 to HLA Class I antigens, reported a
high detection rate of these molecules in the ductal
epithelium of non-malignant breast tissue, but
marked heterogeneity in the epithelium of
malignant tumours.
Selective absorption from plasma of HLA Class I
antigens on to the surface of epithelial cells, or
masking by circulating antibody to Class I
molecules are not adequate explanations of the
inter- and intra-tumour variation observed with
2A1, although subtle undefined conformational
changes in the monomorphic determinant which
might render it unreactive with the monoclonal
antibody could conceivably occur. The data rather
suggest that the expression of HLA Class I
molecules in a major group of primary malignant
breast tumours is reduced.
The reduction of HLA Class I antigens or their
heterogeneous distribution within a neoplasm may
have important biological implications e.g. for the
associative recognition of tumour antigens by T
cells and hence for immunosurveillance.
However, there was no apparent qualitative or
quantitative correlation between leucocyte
infiltration and HLA Class I antigen expression. In
this report our data contrast with recent experience
with dysplastic and malignant nevomelanocytes
where the degree of mononuclear cell infiltration
correlated with the expression of HLA (or f2
microglobulin) on nevomelanocytes (Ruiter et al.,
1982).
Staining with the anti HLA-DR McAb
(TDR31.1) also comprised lymphoid and non-
lymphoid cells. The numbers of leucocytes stained
were usually less than those stained with either 2D1
or UCHT1, suggesting that not all the tumour-
associated T cells were DR+. However, the extent
of T cell activation by this criterion alone is
difficult to assess since an anti HLA-DR McAb
would also be expected to strain the minority
(- 25% leucocytes) B cell and monocyte/macrophage
populations. The deployment of the Tac
monoclonal antibody to the IL-2 receptor on
activated T cells (Uchiyama et al., 1981) might
resolve the issue.HLA & LEUCOCYTE ANTIGENS IN BREAST DISEASE
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Figure 1 2A1 (anti HLA-A, -B, -C)-positive inter-
epithelial leucocytes and periductal cells. Epithelial cell
staining is variable. (Table I, Case 006, adenosis).
( x 170).
Figure 3 TDR31.1 (anti HLA-DR)-positive epithelial
and periductular cells. (Table I, Case 013,
adenosis/fibrosis). Note the variation in staining
intensity among the ducts. (x 170).
Figure 2 2A1 (anti HLA-A, -B, -C)-positive cells in
an infiltrating ductal carcinoma (Table II, Case 021).
The heterogeneous staining pattern is typical of
approx. 50% of the malignant tumours in this series.
( x 170).
Figure 4 2D1 (anti common leucocyte)-positive
interepithelial and periductal cells. Epithelial cells are
negative. (Table I, Case 002). ( x 150).
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Figure 5 2D1 (anti common leucocyte)-positive round
cells surrounding a duct carcinoma. (Table II, Case
021). (x70).
Figure 7 UCHT1 (anti pan T cell)-positive round
cells surrounding duct carcinoma cells. (Table II, Case
021). ( x 170).
Figure 6 UCHT1 (anti pan T cell)-positive inter-
epithelial and periductal cells. (Table I, Case 002,
adenosis). (x 170).
Figure 8 Preponderance of OKT4 (anti T helper)-
positive cells in a duct carcinoma (Table II, Case 021).
(Osmium tetroxide treated, x 170).HLA & LEUCOCYTE ANTIGENS IN BREAST DISEASE 169
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Figure 9 OKT8 (anti T cytotoxic/suppressor) cells in
a duct carcinoma. Area adjacent to field in Figure 8.
OKT8-positive cells in this tumour are fewer than
those positive for OKT4 (x 170).
Figure 11 OKMl (anti monocyte/LGL)-positive cells
around a dilated duct of a benign lesion. (Table I,
Case 041). (x 170).
.. w ...
Figure 10 HNK1 (anti NK/K)-positive myoepithelial
cells with very occasional positive interepithelial cells.
(Table I, Case 002). (Osmium tetroxide treated,
x 170).
Figure 12 OKM1 (anti monocyte/LGL)-positive cells
within the fibrous stroma of a mucoid carcinoma.
(Table II, Case 019). (x 170).170 H.L. WHITWELL et al.
The variability of expression of HLA-DR on
epithelial cells is consistent with previous immuno-
histological studies of these antigens on human
bronchial, intestinal and mammary epithelia (Natali
et al., 1981b), where extrinsic factors such as
hormonal changes associated with pregnancy and
lactation (Klareskog et al., 1980) and the
development of graft versus host disease (Lampert
et al., 1981; Mason et al., 1981) are influential. The
anomalous expression of HLA-DR antigens on
solid human tumours is of comparatively more
recent description (Natali et al., 1981a; Gatter et
al., 1982; Daar et al., 1982; Daar & Fabre, 1983).
Several other cell types involved in immune and
inflammatory processes also express Ia antigens
(Steinman et al., 1981; Hammerling, 1976), but the
mechanism(s) of induction is largely unknown.
Since la antigens are important in cell:cell
interactions and in antigen presentation (Lonai et
al., 1981), the expression of similar molecules on
tumour cells could have implications for the
induction of immune responses to putative tumour-
associated antigens. However, why this should be a
property of only some tumour cells (including those
of benign origin) requires further investigation.
Staining with the antibodies 2D1, UCHTI,
OKT4, OKT8 and MAS020 disclosed two features
which differed in malignant tumours from those in
benign tumours. First, leucocyte infiltration
although variable, was generally more intense.
Second, the microanatomical distribution of the
leucocytes differed insofar as they were principally
to be found surrounding foci of malignant cells as
distinct from being largely confined to the ducts in
benign tumours. In other respects there was little
distinction between benign and malignant tissues;
the infiltrative leucocytes were predominantly
(- 75%) T cells and the subset (OKT4/OKT8)
ratios of the order of those reported for peripheral
blood (McCluskey et al., 1983). However, in some
tumours there appeared to be a shift toward the
suppressor/cytotoxic subset.
Other leucocytes were monitored by the
monoclonal antibodies OKM1 and HNK1.
Immunofluorescence flow cytometry data have
shown that OKM1 is reactive with peripheral blood
monocytes, granulocytes and a major proportion of
circulating NK cells (large granular lymphocytes)
(Ortaldo et al., 1981). Although in positively
stained sections, not all cells could be unequivocally
identified without recourse to double-labelling
techniques, macrophages appeared to be the
predominant cell type. The presence of OKM1+
cells in the ducts is consistent with macrophages
being a component of the interepithelial leucocyte
population of the human mammary gland and also
accounts for the detection of similar cells in the
alveolar lumina (Selig & Beer, 1981).
The OKM1+ cells present in the leucocyte
infiltrates of the malignant tumours were also
morphologically consistent with macrophages,
though staining of large granular lymphocytes
could not be ruled out solely on these grounds.
OKM1+ cells were numerically fewer than T cells
recognised by the UCHT1 antibody and were thus
a minority component of all the infiltrates. There
was no clear numerical or microanatomical
relationship between OKT4+ (T helper) and
OKM1+ cells. In common with T cells, OKM1+
cells were mostly confined to the stromal reaction;
relatively few had penetrated tumour foci.
Functional data on recovered macrophages
attributing them with an in vivo cytotoxic role
should be interpreted in this awareness.
Although in this study relatively few sections
were stained with the monoclonal antibody HNK1,
two points of interest emerged. The positive cells in
benign sections corresponded largely to ductal
interepithelial leucocytes and by contrast with the
other monoclonal antibodies used here, there was
consistent staining of myoepithelial cells. The
significance of this cross-reactivity and the
relationship between HNK1 and other markers of
myoepithelial cells (Bussolati et al., 1983) is
unknown. The second observation was the virtual
absence of HNK1 + cells from the 3 malignant
tumours which were examined. HNK1+ cells are
heterogeneous, but since a proportion express T cell
markers (Abo et al., 1982a), this observation is
somewhat surprising and could point to some
selectivity in extravasation. It should not, however,
be taken to indicate that there are no NK cells in
breast cancers since not all NK/K cells react with
HNK1( Abo, 1982b). Even so, there are likely to be
few: since up to 60% of HNK1 + cells are also
OKM1+ (Abo et al., 1982a) it would appear that
most of the OKM1 + cells in the tumours are
macrophages. This conclusion accords with
functional studies conducted with lymphoid cells
recovered from freshly disaggregated neoplasms
wherein breast, in common with other solid
tumours has generally disclosed low or non-existent
levels of NK activity, (Vose et al., 1977; Totterman
et al., 1978; Moore & Vose, 1981; Eremin et al.,
1981; Introna et al., 1983). The recent availability
of McAbs with greater selectivity for NK cells
should allow further examination of this question
(Perussia et al., 1983a, b).
Note added in proof
Since this manuscript was submitted, similar data
supporting the major findings of this study haveEXPRESSION OF MAJOR HISTOCOMPATIBILITY ANTIGENS 171
appeared elsewhere. See Bhan, A.K. & Des
Marais, C.L. (1983). Immunohistologic
characterization of major histocompatibility
antigens ofinflammatory cellular infiltrate in human
breast cancer, J. Natl Cancer Inst., 71, 507.
This study was supported by the Cancer Research
Campaign.
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